1.2M
Downloads
968
Episodes
Dr Jack Cush reviews the news, journal reports and regulatory decisions from the past week on RheumNow.com
Episodes
Friday Jul 08, 2022
Friday Jul 08, 2022
Dr. Jack Cush recants the top stories and changes for the field of rheumatology in 2021.
My Top 10 list
1. New FDA Approvals: voclosporin, anifrolumab, avacopan, efgartigimod
2. New FDA Indications
3. New Biologics for Lupus
4. Super "H" Hydroxychloroquine
5. Zoomatology
6. Avacopan
7. Tocilizumab
8. FDA & JAK inhibitor warnings
9. New Biologics for GCA
10. IL-23 Inhibitors
https://rheumnow.com/news/2021-rheumatology-year-review-172022
No comments yet. Be the first to say something!